iiinova — where your digital self keeps evolving

Journal of Cardiac Failure @jcardfail.bsky.social · 2h

In young heart transplant candidates, is it best to pursue an LVAD-first approach or proceed directly to transplant? This JCF Focus Issue offers a debate, with perspective pieces for and against an LVAD-first approach.

100

Journal of Cardiac Failure @jcardfail.bsky.social · 23/09/2026

🫀 Donor heart preservation is moving beyond the ice box. From controlled hypothermia & ex-vivo perfusion to HOPE and 10°C storage, this State-of-the-Art review explores technologies poised to expand donor utilization and reshape heart transplantation. 🔗 bit.ly/4iUVj9L

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/09/2026

🚨New Science Alert! 🫀DCD heart transplantation has expanded rapidly nationwide to more centers & higher-risk recipients. Yet graft failure, mortality & other early outcomes remained stable. This UNOS analysis supports the robustness & scalability of DCD. 🔗 bit.ly/3SOqgSx

100

Journal of Cardiac Failure @jcardfail.bsky.social · 17/09/2026

🫀Does heart allocation measure how sick a patient is, or what treatment they receive? This State-of-the-Art review examines the unintended consequences of therapy-based status tiers & makes the case for continuous, objective measures of medical urgency. 🔗 bit.ly/4iRCqo7

000

Journal of Cardiac Failure @jcardfail.bsky.social · 15/09/2026

🌍How do countries decide who gets a donor heart first? This research article analyzes heart allocation policies globally. Across 29 countries, 93% of allocation systems use urgency tiers. But how urgency, MCS priority, & exceptions are defined varies widely. 🔗 bit.ly/4xN1bXq

111

Journal of Cardiac Failure @jcardfail.bsky.social · 14/09/2026

⏰Final Call Submissions for JCF's Focus Issue: The New Frontier of Heart Function in Women close soon. If your research advances women's cardiovascular health, now's the time to submit. 📅Submissions close 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 10/09/2026

💥Could we incentivize cardiac recovery without jeopardizing transplant access? A proposed “Safety Net” would let selected patients pursue LVAD+GDMT for recovery while preserving elevated Tx status if recovery fails. Could this decongest the waitlist?🫀 🔗 bit.ly/4zoKmmJ

000

Journal of Cardiac Failure @jcardfail.bsky.social · 09/09/2026

🫀 Heart transplantation is entering a new era! This State-of-the-Art review explores advances reshaping the field: individualized LVAD vs transplant decisions, DCD & HCV+ donors, and new organ preservation strategies expanding the donor pool. 🔗 bit.ly/45xVQXm 🧵👇

110

Journal of Cardiac Failure @jcardfail.bsky.social · 09/09/2026

What's next in heart transplantation? 🫀 Find out in the September Focus Issue on Innovations in Heart Transplantation. Explore research and perspectives on new developments advancing heart transplantation care. 🔗 onlinejcf.com/current #HeartTransplantation #Cardiology

000

Journal of Cardiac Failure @jcardfail.bsky.social · 08/09/2026

🚨New science alert! PAWP or LVEDP ... which better predicts outcomes? Using simultaneous invasive hemodynamics at rest & during exercise, this study found that PAWP better reflected hemodynamic abnormalities & predicted adverse HF outcomes. 🫀 🔗 bit.ly/4x64Z5K

110

Journal of Cardiac Failure @jcardfail.bsky.social · 03/09/2026

⏳ The deadline is approaching. JCF is still accepting submissions for the upcoming Focus Issue: The New Frontier of Heart Function in Women. If your research advances women's cardiovascular health, we encourage you to submit by 9/15/26. bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 02/09/2026

🧬 Precision medicine begins with a diagnosis. In the largest real-world study to date, only 1.05% of patients with cardiomyopathy underwent genetic testing and just 7% received genetic counseling. Implementation — not evidence — remains the challenge. 🔗 bit.ly/4qpMbvF

011

Journal of Cardiac Failure @jcardfail.bsky.social · 27/08/2026

🫀Does transplant center volume influence DCD heart transplant outcomes? This UNOS analysis found similar perioperative outcomes and short-term survival at high & low-volume centers, supporting the growing robustness & reproducibility of DCD transplantation. 🔗 bit.ly/3U4HUl9

100

Journal of Cardiac Failure @jcardfail.bsky.social · 26/08/2026

Women's cardiovascular health deserves research that reflects their experiences. Submit to JCF's Focus Issue: The New Frontier of Heart Function in Women. 📅 Submit by 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 25/08/2026

🫀Is predicted heart mass still the best way to size-match donor hearts? This Perspective questions PHM in the modern era, highlighting its limitations in obesity & calling for next-generation metrics that better reflect body composition & cardiac size. 🔗 bit.ly/45xRZtm

001

Journal of Cardiac Failure @jcardfail.bsky.social · 20/08/2026

🫀Out-of-sequence heart transplantation remains uncommon. But it's growing. This study found OOS allocation increased from 1.4% to 3.1%, was concentrated in a small number of OPOs & centers, & achieved similar 1-year survival to standard allocation. 🔗 bit.ly/4qhMFDS

101

Journal of Cardiac Failure @jcardfail.bsky.social · 18/08/2026

Out now! The August issue of JCF is live. Catch up on the latest research and insights in heart failure. See what’s inside 👉 onlinejcf.com/current #HeartFailure #Cardiology #HeartFailureResearch

000

Journal of Cardiac Failure @jcardfail.bsky.social · 11/08/2026

The future of women's cardiovascular care starts with today's research. Submit your work to JCF's Focus Issue: The New Frontier of Heart Function in Women. 📅 Deadline: 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 06/08/2026

How reliable is urine sodium concentration during continuous IV diuresis? This Brief Report found substantial temporal variability in urine sodium despite stable loop diuretic infusions, raising questions about its role in monitoring diuretic response. 🔗 bit.ly/4wKoG2A

010

Journal of Cardiac Failure @jcardfail.bsky.social · 05/08/2026

New science alert! Do AF, diabetes, or obesity change the benefits of aspirin withdrawal after HM3 LVAD?💖 This ARIES-HM3 analysis says no. Bleeding decreased without increases in stroke or thrombosis, even in these higher-risk subgroups.🩸 🔗 bit.ly/4gbLxhI

100

Journal of Cardiac Failure @jcardfail.bsky.social · 04/08/2026

Hear from the guest editors leading The New Frontier of Heart Function in Women as they share their excitement for this upcoming focus issue. 📅 Submissions open through Sept. 15th: bit.ly/4fC1NZh #WomensHeartHealth #HeartFailure #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 30/07/2026

🫀🤖 Digital twins may help transform HF care from reactive to anticipatory! This JCF Perspectives article explores how patient-specific computational models or "digital twins" could enable earlier detection of instability and more personalized care. 🔗 bit.ly/3TMBHKp

010

Journal of Cardiac Failure @jcardfail.bsky.social · 28/07/2026

How great is the burden of ATTR-CM? 🫀 In this study using the GWTG-HF registry, patients with ATTR-CM had higher HF readmission rates and greater healthcare costs, despite similar adjusted mortality. Earlier diagnosis and treatment remain critical! 🔗 bit.ly/3RhHBCH

100

Journal of Cardiac Failure @jcardfail.bsky.social · 23/07/2026

Can interatrial shunts help HFpEF? This State-of-the-Art Review revisits atrial shunt therapy, highlighting how phenotyping, invasive exercise hemodynamics & pulmonary vascular assessment may identify responders while avoiding harm in nonresponders. 🔗 bit.ly/45pzqY5

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/07/2026

Call for Papers 📃 JCF invites research examining cardiovascular health from adolescence through healthy aging for our upcoming Focus Issue: The New Frontier of Heart Function in Women. 📅 Deadline: 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 21/07/2026

Can we detect worsening HF before symptoms develop?📡❤️ A novel personalized congestion score derived from an IVC sensor predicted worsening HF events w/92.6% sensitivity & correlated with NT-proBNP levels. Early detection may enable more proactive HF management. bit.ly/44HJTOp

100

Journal of Cardiac Failure @jcardfail.bsky.social · 16/07/2026

Could sleep apnea be a key driver of adverse outcomes in HFpEF?❤️‍🩹 In a PARAGON-HF analysis, patients with SA had greater LV remodeling, worse BiV strain & 57% ⬆️ risk of HFH or CV death. SA may represent an important, modifiable HFpEF phenotype. onlinejcf.com/article/S107...

100

Journal of Cardiac Failure @jcardfail.bsky.social · 15/07/2026

How is vericiguat being used in real-world HFrEF care? ❤️‍ In a study of >5,100 US patients following a worsening HF event, only ~36% reached the target 10 mg dose. Patients already receiving robust GDMT were more likely to achieve target dosing. 💊📊 🔗 onlinejcf.com/article/S107...

100

Journal of Cardiac Failure @jcardfail.bsky.social · 14/07/2026

🫀 The July edition of JCF is here! Featuring the latest perspectives and studies on heart failure and patient care. 🔗 Read the full issue: onlinejcf.com/current

000

Journal of Cardiac Failure @jcardfail.bsky.social · 09/07/2026

📣 Call for Papers JCF is accepting submissions for our focus issue: The New Frontier of Heart Function in Women Research spanning the female lifespan, from reproductive health to HFpEF, prevention, and heart failure is encouraged. 📅 Submit by 9/15/26 bit.ly/4xQkPSR #WomensHeartHealth

110

Journal of Cardiac Failure @jcardfail.bsky.social · 08/07/2026

Can LVADs do more than support circulation? 🫀 This JCF Ignite! article explores whether LVAD-mediated unloading can promote reverse remodeling and myocardial recovery, and whether some patients might benefit from LVAD therapy as a bridge to regeneration. ❤️‍🩹 🔗 bit.ly/3S0UHEj

000

Journal of Cardiac Failure @jcardfail.bsky.social · 07/07/2026

How should palliative care fit into advanced HF care? 💙 The HeartPal program embedded palliative care directly within an advanced heart disease service, resulting in earlier referrals, more GoC discussions, fewer late referrals & reduced in-hospital deaths. 🫀 🔗 bit.ly/3S4btlS

100

Journal of Cardiac Failure @jcardfail.bsky.social · 02/07/2026

🚨HF-CS is now more common than AMI-CS. This State-of-the-Art Review examines how microaxial flow pumps are reshaping HF-CS care through LV unloading, prolonged support, hemodynamic-guided management, and bridge-to-recovery/transplant strategies. 🫀📊 🔗 bit.ly/4ez3oye

000

Journal of Cardiac Failure @jcardfail.bsky.social · 01/07/2026

🚨 What is the optimal MAP target in AMI-CS? This meta-analysis found no mortality benefit with higher MAP targets vs lower targets. 📊 The findings challenge a "higher is better" approach & highlight the need for individualized perfusion goals. ❤️‍🩹 🔗 bit.ly/4vL6dSW

000

Journal of Cardiac Failure @jcardfail.bsky.social · 30/06/2026

Not all cardiogenic shock is the same!🚨 In the CSWG Registry, patients with HF-CS treated with femoral IABP had ⬇️ mortality, ⬆️ rates of native heart 🫀 survival & more frequent bridging to heart replacement therapy than those with AMI-CS. 🔗 bit.ly/4uqv50Y

000

Journal of Cardiac Failure @jcardfail.bsky.social · 23/06/2026

Can hemodynamic trends help identify 🫀recovery during tMCS? In the UNLOADERS-PVAD Registry, pts supported with VA-ECMO+mAFP demonstrated distinct improvements in CO & functional indices during ECMO weaning. Serial hemodynamics may help guide recovery assessment. 📊 🔗 bit.ly/4vGJN5b

000

Journal of Cardiac Failure @jcardfail.bsky.social · 22/06/2026

📢 Call for Papers Focus Issue: The New Frontier of Heart Function in Women Guest Editors Drs. Anuradha Lala, Martha Gulati, Novi Yanti Sari, and Diana de Oliveira-Gomes will lead this issue, publishing in February '27. Categories & topic areas: bit.ly/4vjovuq 🗓 Submit by Sept. 15!

000

Journal of Cardiac Failure @jcardfail.bsky.social · 17/06/2026

We are proud of the progress reflected in this year’s Impact and Impact Factor of 9.9, but even more proud of what all of this represents. 🎉 A heartfelt THANK YOU to our entire JCF Family. Your engagement as authors, reviewers, readers, and mentors continues to drive this collective success.

010

Journal of Cardiac Failure @jcardfail.bsky.social · 16/06/2026

🫀 Infiltrative & inflammatory cardiomyopathies share common pathways of dysfunction Advanced imaging is shifting from structure → biology. Probing inflammation, microvascular dysfunction, and energetics to refine diagnosis and guide precision HF care. 📊 🔗 bit.ly/4v2Oi9I

000

Journal of Cardiac Failure @jcardfail.bsky.social · 15/06/2026

Last call! 🚨 Submissions close today for JCF’s Focus Issue - Artificial Intelligence and Heart Failure: A Critical Juncture. Don’t miss the opportunity to contribute at this defining moment in HF care. 🫀 bit.ly/4kJl5gf #HeartFailure #AIinHealthcare #CallForPapers

000

Journal of Cardiac Failure @jcardfail.bsky.social · 10/06/2026

Can AI improve detection of infiltrative & inflammatory cardiomyopathies? Emerging data (strongest in amyloidosis) suggest roles in detection & risk stratification, but most evidence remains retrospective and biased. AI may augment (not replace) clinical care. 🫀💻 bit.ly/4uvE0Ps

010

Journal of Cardiac Failure @jcardfail.bsky.social · 09/06/2026

What's new in heart failure research? Find out in the June edition of JCF, featuring expert perspectives advancing our understanding of heart failure and informing patient care. Read the full issue: onlinejcf.com/current

021

Journal of Cardiac Failure @jcardfail.bsky.social · 09/06/2026

In ATTR-CM, acoramidis increased serum TTR and reduced CV death/hospitalization in ATTRibute-CM. Early rises in TTR were linked to lower risk, suggesting sTTR may be a useful biomarker of treatment response. 🫀🧪 bit.ly/4dPjwKD

020

Journal of Cardiac Failure @jcardfail.bsky.social · 04/06/2026

Time is running out to submit to JCF’s Focus Issue - Artificial Intelligence and Heart Failure: A Critical Juncture. If your work advances responsible innovation in HF care, now is the time to contribute. ⌛ 🗓️ Deadline: May 10, 2026 bit.ly/4kJl5gf #HeartFailure #AIinHealthcare

000

Journal of Cardiac Failure @jcardfail.bsky.social · 03/06/2026

In HELIOS-B, vutrisiran slowed renal decline in ATTR-CM: fewer ≥40% eGFR drops vs placebo (12.7% vs 21.2%). Benefits on CV outcomes were consistent across kidney function, even in advanced CKD. Improves not just CV outcomes, but has renal benefits! 🫀🧪 bit.ly/3Q2hhf1

010

Journal of Cardiac Failure @jcardfail.bsky.social · 02/06/2026

Cardiac sarcoidosis: beyond steroids? The REPAIR-CS trial is testing rilonacept (IL-1 blockade) added to standard therapy, with FDG-PET inflammation as the primary endpoint—marking a shift toward targeted, mechanism-based treatment. 🫀 🔗 bit.ly/3RijCTs

000

Journal of Cardiac Failure @jcardfail.bsky.social · 28/05/2026

When should we biopsy for cardiac sarcoidosis? In ILLUMINATE-CS, EMB positivity (~22%) was directionally associated with established predictors (MIDFIN). Novel predictors: septal thickness, FDG-PET burden, BNP). EMBx yield rose stepwise with number of criteria. bit.ly/4wDDkcf

100

Journal of Cardiac Failure @jcardfail.bsky.social · 27/05/2026

The latest State of the Art Review looks at Immune-mediated pericardial & myocardial syndromes as unified spectrum: linking 🧬 susceptibility, 🌍 triggers & systemic inflammation, with integrated diagnostics & expanding therapies (incl. biologics). 🔗 bit.ly/4dEFcZX

001

Journal of Cardiac Failure @jcardfail.bsky.social · 26/05/2026

Acute myocarditis: who is truly at risk? In a real-world cohort, most patients had favorable outcomes (~88% event-free at 10 yrs). But higher risk was linked to age, HF symptoms, and LV hypokinesia, highlighting the value of early bedside assessment. 🫀📊 bit.ly/4dSSd39

100

Journal of Cardiac Failure @jcardfail.bsky.social · 18/05/2026

Referral to advanced HF care improves outcomes, but often comes too late. This SOTA Review highlights a persistent referral gap driven by access, awareness, and provider factors, and outlines practical solutions to improve timing and equity. 🫀📊 🔗 bit.ly/4uaK53h

000